In addition to the glutamate system and electrophysiological characteristics, we examined the effect of ACSS2 upregulation on the pathological phenotype of AD, including Amyloid beta (Aβ) -deposition and gliosis [35, 52]. Here, ACSS2 is linked to Alzheimer disease.